141 related articles for article (PubMed ID: 20936705)
1. The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
Di Domenico F; Owen JB; Sultana R; Sowell RA; Perluigi M; Cini C; Cai J; Pierce WM; Butterfield DA
J Neurosci Res; 2010 Dec; 88(16):3566-77. PubMed ID: 20936705
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule.
Reed TT; Pierce WM; Turner DM; Markesbery WR; Allan Butterfield D
J Cell Mol Med; 2009 Aug; 13(8B):2019-2029. PubMed ID: 18752637
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
[TBL] [Abstract][Full Text] [Related]
6. Subregions of the inferior parietal lobule are affected in the progression to Alzheimer's disease.
Greene SJ; Killiany RJ;
Neurobiol Aging; 2010 Aug; 31(8):1304-11. PubMed ID: 20570398
[TBL] [Abstract][Full Text] [Related]
7. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
Cenini G; Sultana R; Memo M; Butterfield DA
J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
[TBL] [Abstract][Full Text] [Related]
8. Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
Triplett JC; Swomley AM; Cai J; Klein JB; Butterfield DA
J Alzheimers Dis; 2016; 49(1):45-62. PubMed ID: 26444780
[TBL] [Abstract][Full Text] [Related]
9. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
[TBL] [Abstract][Full Text] [Related]
10. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
Lovell MA; Smith JL; Xiong S; Markesbery WR
Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263
[TBL] [Abstract][Full Text] [Related]
11. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule, a proteomics approach.
Newman SF; Sultana R; Perluigi M; Coccia R; Cai J; Pierce WM; Klein JB; Turner DM; Butterfield DA
J Neurosci Res; 2007 May; 85(7):1506-14. PubMed ID: 17387692
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
13. Lectin-affinity chromatography brain glycoproteomics and Alzheimer disease: insights into protein alterations consistent with the pathology and progression of this dementing disorder.
Butterfield DA; Owen JB
Proteomics Clin Appl; 2011 Feb; 5(1-2):50-6. PubMed ID: 21280237
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.
Sultana R; Reed T; Perluigi M; Coccia R; Pierce WM; Butterfield DA
J Cell Mol Med; 2007; 11(4):839-51. PubMed ID: 17760844
[TBL] [Abstract][Full Text] [Related]
15. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
[TBL] [Abstract][Full Text] [Related]
16. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
Peng S; Wuu J; Mufson EJ; Fahnestock M
J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
[TBL] [Abstract][Full Text] [Related]
17. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
[TBL] [Abstract][Full Text] [Related]
18. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.
Sultana R; Perluigi M; Newman SF; Pierce WM; Cini C; Coccia R; Butterfield DA
Antioxid Redox Signal; 2010 Mar; 12(3):327-36. PubMed ID: 19686046
[TBL] [Abstract][Full Text] [Related]
19. Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease.
Lynn BC; Wang J; Markesbery WR; Lovell MA
J Alzheimers Dis; 2010; 19(1):325-39. PubMed ID: 20061648
[TBL] [Abstract][Full Text] [Related]
20. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.
Cohen AD; Price JC; Weissfeld LA; James J; Rosario BL; Bi W; Nebes RD; Saxton JA; Snitz BE; Aizenstein HA; Wolk DA; Dekosky ST; Mathis CA; Klunk WE
J Neurosci; 2009 Nov; 29(47):14770-8. PubMed ID: 19940172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
